Chiropractors in Bay St. Louis, MS Accepting Medicare
2 Chiropractors found. Showing 1 - 2
 Hancock Chiropractic Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 806 Hwy 90, Bay St. Louis, MS 39520 Phone: 228-463-1778 |
 Robert R Guenther, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 806 Highway 90, Bay St. Louis, MS 39520 Phone: 228-466-2900 Fax: 228-466-2999 |
News Archive
IMRIS common shares commence trading on NASDAQ Global Market
IMRIS Inc. announced today that its common shares have commenced trading on the NASDAQ Global Market under the symbol "IMRS". IMRIS' common shares are dual listed on the Toronto Stock Exchange and the NASDAQ Global Market.
Targeting physical activity is not the effective way to reduce prolonged sitting
Targeting sitting time, rather than physical activity, is the most effective way to reduce prolonged sitting, according to the first comprehensive review of strategies designed to reduce sitting time. The research, led by the Institute of Psychiatry, Psychology & Neuroscience at King's College London, is published in the journal Health Psychology Review.
Brookdale Senior Living announces sale of 10,000,000 shares by Fortress Investment Group affiliates
Brookdale Senior Living Inc. announced today the sale of an aggregate of 10,000,000 shares of its common stock by certain affiliates of Fortress Investment Group LLC. The Company will not sell any shares in the offering and will not receive any of the proceeds from the offering. Subject to customary conditions, the offering is expected to close on May 17, 2010.
‘Designer molecules' being developed to fight disease
Researchers in the Department of Cardiovascular Sciences at the University of Leicester are developing a new way to make protein based drugs with potential applications in stroke, vascular inflammation, blood vessel formation, regenerative medicine and tissue engineering.
AVI BioPharma's peptide-conjugated PMO chemistry to be discussed at two upcoming scientific meetings
AVI BioPharma, Inc., a developer of RNA-based drugs, today announced that Hong Moulton, Ph.D., Director of Discovery Research, will give oral presentations highlighting improved analogues of AVI's phosphorodiamidate morpholino oligomer (PMO) chemistry at two upcoming scientific meetings.
› Verified 5 days ago